Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
- DOI
- 10.1016/s0140-6736(25)00861-x
- Published
- 2025 Oct 4
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-25-00861-x,
title = {Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.},
author = {Hatter L and Holliday M and Oldfield K and Kearns C and Barry T and Black M and Bruce P and Colman A and Dickinson E and Eathorne A and Harwood M and Hills T and Lamb R and Kerse K and Krishnamoorthy S and Martindale J and Semprini A and Shortt N and McNamara D and Byrnes CA and Dalziel SR and Bush A and Weatherall M and Beasley R and CARE study team},
year = {2025},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(25)00861-x},
url = {https://doi.org/10.1016/s0140-6736(25)00861-x}
}RIS
TY - JOUR TI - Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial. AU - Hatter L AU - Holliday M AU - Oldfield K AU - Kearns C AU - Barry T AU - Black M AU - Bruce P AU - Colman A AU - Dickinson E AU - Eathorne A AU - Harwood M AU - Hills T AU - Lamb R AU - Kerse K AU - Krishnamoorthy S AU - Martindale J AU - Semprini A AU - Shortt N AU - McNamara D AU - Byrnes CA AU - Dalziel SR AU - Bush A AU - Weatherall M AU - Beasley R AU - CARE study team PY - 2025 JO - Lancet (London, England) DO - 10.1016/s0140-6736(25)00861-x UR - https://doi.org/10.1016/s0140-6736(25)00861-x ER -
APA
L, H., M, H., K, O., C, K., T, B., M, B., P, B., A, C., E, D., A, E., M, H., T, H., R, L., K, K., S, K., J, M., A, S., N, S., D, M., CA, B., SR, D., A, B., M, W., R, B., & team, C. S. (2025). Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)00861-x
Source records
- pubmed · retrieved 2026-09-27T15:11:31.899Z